DermAbiotech Sàrl develops targeted therapies for acute T cell–mediated inflammatory diseases. The company focuses on therapeutic candidates designed to modulate T‑cell driven inflammation.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered1
Targeted Therapy Development
Targeted therapy development for acute T cell-mediated inflammatory diseases, focusing on therapeutic approaches for immune-mediated inflammation.
Comparisons
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.